Category: Latest News
-
Valion Bio Completes Oral Mucosal Entolimod Formulation, Opening Potential Needle-Free Development Pathway
Valion Bio and Shear Kershman Laboratories have completed formulation work for oral mucosal Entolimod, with the next study set to determine whether the needle-free approach can deliver measurable levels of the biologic into the bloodstream. Key Investor Takeaways Why VBIO Stock Is in Focus Valion Bio and Shear Kershman Laboratories have completed the formulation stage…
-
DarkIris Advances Cine3.AI Global Rollout and Establishes U.S. Subsidiary for North American Expansion
DarkIris is preparing its AI-powered film production platform for international launch while building a North American operating presence and extending its technology into interactive entertainment. Key Investor Takeaways Why DKI Stock Is in Focus DarkIris is moving closer to the international launch of Cine3.AI while establishing the commercial infrastructure intended to support its expansion into…
-
Silexion Therapeutics Begins Phase 2/3 SIL204 Trial With First Patient Dosed in Pancreatic Cancer
Silexion Therapeutics has moved SIL204 into active patient treatment, beginning a multinational Phase 2/3 study that will evaluate the RNAi candidate alongside standard chemotherapy in locally advanced pancreatic cancer. Key Investor Takeaways Why SLXN Stock Is in Focus Silexion has dosed the first patient worldwide in its Phase 2/3 clinical trial of SIL204, marking the…
-
Leslie’s Chapter 11 Restructuring Targets 90% Debt Reduction and $150 Million in New Capital
The pool and spa retailer has entered a lender-backed restructuring that would cut about $685 million of funded debt, bring in new financing and shift majority ownership to existing lenders. Key Investor Takeaways Why LESL Stock Is in Focus Leslie’s has initiated a prearranged Chapter 11 restructuring designed to reduce its debt burden, secure additional…
-
CoreWeave Launches Partner Network for AI Cloud Integrations
CoreWeave Inc. (NASDAQ:CRWV) announced the launch of the CoreWeave Partner Network, bringing together technology partners whose integrations have been tested on the CoreWeave Cloud platform under production conditions. The network was unveiled at Fully Connected, CoreWeave’s AI cloud conference, which attracted more than 4,500 attendees. CoreWeave said the programme consolidates existing collaborations with companies including…
-
Sagimet Biosciences Shares Rise 12% After Denifanstat Phase 3 Acne Trial Data
Sagimet Biosciences Inc Series A (NASDAQ:SGMT) shares rose more than 12% in pre-market trading on Wednesday following the release of 52-week results from license partner Ascletis’ Phase 3 open-label extension trial evaluating denifanstat in patients with moderate to severe acne. The trial reported a 57% treatment success rate after 52 weeks of denifanstat treatment, alongside…
-
Synopsys and Amazon Sign Multi-Year Silicon IP Agreement Valued at More Than $1 Billion
Synopsys, Inc. (NASDAQ:SNPS) announced a multi-year agreement with Amazon (NASDAQ:AMZN) valued at more than $1 billion, covering silicon intellectual property and engineering software for Amazon’s custom chip development. Under the agreement, Amazon will become the lead customer for Synopsys’ application-optimized silicon IP business. The arrangement expands a collaboration between the companies that has lasted for…
-
Rafael Holdings Shares Fall 25% After Trappsol Cyclo Phase 3 Trial Misses Primary Endpoint
Rafael Holdings Inc Class B (NYSE:RFL) shares fell 25% in pre-market trading on Wednesday after the company’s Phase 3 TransportNPC trial of Trappsol Cyclo in patients with Niemann-Pick Disease Type C (NPC) failed to meet its primary endpoint. The study enrolled 94 patients and evaluated the change from baseline in the 4-domain NPC Clinical Severity…
-
Mattel Shares Fall 3% as Roger Lynch Is Named CEO to Succeed Ynon Kreiz
Mattel Inc (NASDAQ:MAT) shares fell 3% in pre-market trading on Wednesday after the toy company announced that Chief Executive Officer Ynon Kreiz will step down to take a senior leadership position at another publicly traded company. Mattel appointed long-standing board member and Independent Lead Director Roger Lynch as Chairman and Chief Executive Officer. Lynch currently…
-
Oracle Shares Fall 1.8% After Report Flags Potential Wisconsin AI Data Centre Delays
Oracle Corp. (NYSE:ORCL) shares fell 1.8% on Wednesday after infrastructure data provider Aterio reported that the company’s planned artificial intelligence data centre campus in Wisconsin could face delays related to its connection to the regional electricity grid. The reported delays have not been confirmed by Oracle. The company did not immediately respond to requests for…